Category: Cancer Treatment
Global Cancer Treatment
-
2024 Global Forecast for Lung Cancer Surgery Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx ... Read More
-
2024 Global Forecast for Immunotherapy Drugs Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion ... Read More
-
2024 Global Forecast for Metastatic Breast Cancer Treatment Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
2024 Global Forecast for Medical Linear Accelerator Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... countries. The product or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from ... Read More
-
Global Erythropoietin Drugs Market Size study & Forecast, by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa), by Application (Cancer, Renal Disease, Neurology, Others), and Regional Analysis, 2023-2030
... USD 6.87 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 1.5% during the forecast period 2023-2030. Erythropoietin (EPO), also known as hematopoietin, is a glycoprotein hormone that ... Read More
-
Global CAR T-Cell Therapy for Multiple Myeloma Market Growth (Status and Outlook) 2024-2030
... 160.4 million in 2023. With growing demand in downstream market, the CAR T-Cell Therapy for Multiple Myeloma is forecast to a readjusted size of US$ 1063 million by 2030 with a CAGR of 31.0% during ... Read More
-
Global Cancer Monoclonal Antibodies Market Growth 2024-2030
... market, the Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ 63370 million by 2030 with a CAGR of 9.5% during review period. The research report highlights the growth potential of the global ... Read More
-
Global Cancer Vaccines Market Growth 2024-2030
... Cancer Vaccines is forecast to a readjusted size of US$ 12280 million by 2030 with a CAGR of 14.9% during review period. The research report highlights the growth potential of the global Cancer Vaccines market. ... Read More
-
Global Cancer Gene Therapy Market Growth (Status and Outlook) 2024-2030
... demand in downstream market, the Cancer Gene Therapy is forecast to a readjusted size of US$ 1674.2 million by 2030 with a CAGR of 18.5% during review period. The research report highlights the growth potential ... Read More
-
Global Breast Cancer Monoclonal Antibodies Market Growth 2024-2030
... downstream market, the Breast Cancer Monoclonal Antibodies is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Acute Myeloid Leukemia Global Market Report 2024
... DC Regimen; AVD Regimen; VCD Regimen4) By End-User: Hospital; Retails Drug Stores; Ambulatory Care Centers; ClinicsCovering: Pfizer Inc.; F. Hoffmann-La Roche AG; AbbVie Inc.; Novartis AG; Sanofi-Aventis (Genzyme Corporation) Acute Myeloid Leukemia Global Market Report ... Read More
-
Global Vaccine Adjuvants Market Size study&Forecast, byType (Pathogen, Adjuvant emulsion, Particulate, Combination, Others), by Application (Infectious diseases, Cancer, Others), by Administration (Oral, Intradermal, Intranasal, Intramuscular, Others) and Regional Analysis, 2023-2030
... valued at approximately USD1.62 billion in 2022 andis anticipated to grow with a healthy growth rate of more than 2.3%duringthe forecast period 2023-2030.Adjuvants are the ingredients that are added to the vaccinations to increase effectiveness ... Read More
-
Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) - Global Clinical Trials Review, 2024
... - Global Clinical Trials Review, 2024 provides an overview of Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer) Clinical trials scenario. This report provides top line data relating to the clinical ... Read More
-
Ewing Sarcoma - Global Clinical Trials Review, 2024
... data relating to the clinical trials on Ewing Sarcoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials ... Read More
-
Cutaneous Squamous Cell Carcinoma (cSCC) - Global Clinical Trials Review, 2024
... (cSCC) Clinical trials scenario. This report provides top line data relating to the clinical trials on Cutaneous Squamous Cell Carcinoma (cSCC). Report includes an overview of trial numbers and their average enrollment in top countries ... Read More
-
Tumor Ablation Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... billion by 2029, growing at a CAGR of 10.10% during the forecast period (2024-2029). Key Highlights The COVID-19 pandemic affected healthcare systems globally and resulted in the interruption of usual care in many healthcare facilities, ... Read More
-
Community Oncology Services Global Market Report 2024
... Prostate Cancer; Skin Cancer; Pancreatic Cancer; Blood Cancer; Colorectal Cancer 3) By Therapy Type: Medical Oncology; Radiation Oncology; Surgical Oncology Covering: The US Oncology Network; OneOncology; Florida Cancer Specialists & Research Institute (FCS); The Oncology ... Read More
-
Cancer Monoclonal Antibodies Global Market Report 2024
... Cancer 3) By End-User: Hospitals; Research Laboratories Covering: F. Hoffmann-La Roche Ltd; Merck & Co., Inc.; Bristol Myers Squibb Company; Johnson & Johnson; Amgen Inc. Cancer Monoclonal Antibodies Global Market Report 2024 from The Business ... Read More
-
MiRNA Sequencing and Assay Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029. Segmented By Technology (Sequencing by Synthesis, Sequencing by Oligonucleotide Ligation and Detection (SOLiD), Nanopore Sequencing, Sanger Sequencing, Single Molecule Real-time (SMRT) Sequencing), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-use (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage) Region and Competition
... (SMRT) Sequencing), By Application (Cancer, Polyglutamine Diseases, Autoimmune Disease, Schizophrenia, Others), By End-use (Pharmaceutical & Biotechnology Industry, Research and Academic Institutes, Others), By Workflow (Library Preparation, Sequencing, Data Analysis & Storage) Region and Competition Global ... Read More
-
Breast Cancer Core Needle Biopsy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2019-2029 Segmented by Technology (MRI-Based Breast Biopsy, Ultrasound-Based Breast Biopsy, Mammography-Based (Stereotactic) Breast Biopsy, CT-Based Breast Biopsy, Other Image Based Breast Biopsy), By End Use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes), and By Region, Competition
... Breast Biopsy), By End Use (Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology companies, Academic & Research Institutes), and By Region, Competition Global Breast Cancer Core Needle Biopsy Market was valued at USD 0.80 billion in ... Read More
-
Global AI in Cancer Diagnostics Market (2023-2028) by Components, Cancer Type, End-Users, and Geography, IGR Competitive Analysis, Impact of Covid-19, Ansoff Analysis
... 147.61 Mn in 2023 and is expected to reach USD 400.91 Mn by 2028 growing at a CAGR of 22.12%. Market dynamics, which refers to the ever-changing and evolving conditions, trends, and forces that impact ... Read More
-
Chemotherapy-Induced Anemia Global Market Report 2024
... Surgical Centers; Multispecialty Clinics; Cancer Research Centers; Cancer Rehabilitation CentersCovering: Pfizer Inc.; Johnson & Johnson; F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Novartis AG Chemotherapy-Induced Anemia Global Market Report 2024 from The Business Research ... Read More
-
Cervical Cancer Vaccine Global Market Report 2024
... Johnson & Johnson; Merck & Co Inc.; Novartis AG; Sanofi Pasteur Cervical Cancer Vaccine Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need ... Read More
-
Pharmacogenomics Market by Product & Service (Kits & Reagents), Technology (Sequencing, PCR, Microarray), Application (Drug Discovery, Clinical Research, Personalized Medicine), Disease Area (Cancer, Neurological, Cardiovascular) - Global Forecast to 2028
... to reach USD 5.8 billion by 2028 from an estimated USD 3.5 billion in 2023, at a CAGR of 10.6% during the forecast period. The growth of this market can be attributed to the research ... Read More
-
Penile Cancer Global Market Report 2024
... Radiation Therapy; Chemotherapy; Biological Therapy; Surgery3) By Diagnostic Test: Biopsy; Ultrasound; Imaging Tests4) By Application: Hospital; ClinicsCovering: Pfizer Inc.; Merck & Co. Inc.; Bayer AG; Bristol-Myers Squibb Company; Fresenius Kabi AG Penile Cancer Global Market ... Read More
Research Assistance
